[EN] THE COMBINATION OF CYCLIN DEPENDENT KINASE 7 INHIBITOR AND IMMUNOTHERAPY FOR TREATMENT OF CANCER<br/>[FR] ASSOCIATION D'UN INHIBITEUR DE KINASE 7 DÉPENDANTE DE CYCLINES ET D'UNE IMMUNOTHÉRAPIE POUR LE TRAITEMENT DU CANCER
申请人:DANA FARBER CANCER INST INC
公开号:WO2021133601A1
公开(公告)日:2021-07-01
The present disclosure provides methods and compositions related to combination therapy of a CDK7 inhibitor and immunotherapy. The combination of the CDK7 inhibitor and immunotherapy is useful in treating and/or preventing cancer in a subject. The combination therapy may further comprise chemotherapy (e.g., chemotherapeutic agents).